ABL1 and acute myeloid leukemia: The 3‐year probabilities of OS were 81.3% (95% CI: 57.6%–92.6%) and 56.0% (95% CI: 19.7%–81.3%) in the AML with BCR::ABL1 and MPAL with BCR::ABL1 groups, respectively (p = 0.15) (Figure 1A).